Published on in Vol 7, No 4 (2022): Oct-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/40326, first published
.

Journals
- Lei M, Lin B, Ling P, Liu Z, Yang D, Deng H, Yang X, Lv J, Xu W, Yan J. Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial. BMJ Open 2023;13(8):e073263 View
- Liarakos A, Crabtree T, Hussain S, Patel R, Gazis A, Mendis B, Herring R, Kennedy A, Black N, Ryder R, Wilmot E. Long-Term Improvements in Glycemia and User-Reported Outcomes Associated with Open-Source Automated Insulin Delivery Systems in Adults with Type 1 Diabetes in the United Kingdom: A Real-World Observational Study. Diabetes Technology & Therapeutics 2025;27(4):283 View